Walter Klemp is the founder of Moleculin. Moleculin has raised $750M in total funding.
Walter Klemp is the Founder and Chairman of Moleculin Biotech, a pharmaceutical company focused on hard-to-treat tumors and viruses. He has also founded and chaired two other Nasdaq-listed biotech companies, MBRX and SOLY. Across his companies, Klemp has raised over $750 million in development-stage funding, including multiple public securities issuances and Nasdaq IPOs.
Full founder directory · Investor directory · Company funding database · Fundraising library